期刊文献+

Peroxiredoxin 2基因RNAi慢病毒载体构建及对SW480细胞增殖的影响

Construction of lentiviral vector of peroxiredoxin 2 gene mediating RNAi and its effects on the proliferation of SW480 cell
下载PDF
导出
摘要 目的构建Peroxiredoxin2(PRDX2)基因RNA干扰(RNA interference,RNAi)慢病毒表达载体,探讨PRDX2基因干扰后对结直肠癌SW480细胞增殖的影响。方法设计、合成靶向PRDX2的RNA干扰的序列,构建pGC-EGFP-shPRDX2慢病毒载体并进行鉴定,同时应用qRT-PCR和Western blot方法观察转染的SW480结肠癌细胞PRDX2 mRNA和蛋白表达的抑制效果,并通过MTT、平板克隆形成实验检测细胞增殖变化。结果成功构建PRDX2基因慢病毒载体并经测序证实;pGCEGFP-shPRDX2可有效抑制结直肠癌SW480细胞PRDX2的表达,感染慢病毒的SW480细胞中PRDX2 mRNA和蛋白表达水平明显降低(P<0.05);SW480细胞经PRDX2 RNA干扰后其生长和增殖能力显著降低(P<0.05)。结论 PRDX2基因RNAi慢病毒表达载体在SW480细胞中表达稳定可靠,PRDX2基因干扰后有效抑制了结直肠癌SW480细胞的增殖和生长,为进一步探讨PRDX2在结直肠癌发生、发展及转移中的作用奠定基础。 Objective To construct a lentiviral expression vector of peroxiredoxin2(PRDX2) RNA interference (RNAi) and to investigate the effect of siRNA of PRDX2 genes on the proliferation of human colonrectal cancer SW480 cell .Methods RNAi target sequences were designed and synthesized towards the PRDX2 gene sequences .The lentiviral vector pGC-EGFP-shPRDX2 was constructed and identified .The vector was transformed into SW480 cells ,and the transfection efficiency was evaluated by fluorescence microscopy .The expression of PRDX2 was detected with Quantitative real-time PCR (qRT-PCR) and Western blot in the transfected cells .Cell growth and colony forming ability were detected with MTT and plate cloning technique .Results PRDX2 gene lentiviral vector was successfully established and was proved by gene sequencing .The expression of PRDX2 in mRNA and protein was significantly reduced(P〈0 .05) .The PRDX2 mRNA and protein expression in SW480 transfected with lentiviral were sig-nificantly reduced (P〈 0 .05) ,and the ability of growth and proliferation were significantly reduced(P〈 0 .05) .Conclusion PRDX2 gene lentiviral vector could be a stable and reliable tool .The proliferation and growth of SW480 cells transfected by pGC-EGFP-shPRDX2 could be effectively suppressed ,which could facilitate further investigation of the roles of PRDX2 gene in the development and progression of colorectal cancer .
出处 《重庆医学》 CAS 北大核心 2015年第1期14-17,20,共5页 Chongqing medicine
基金 国家自然科学基金资助项目(81172295)
关键词 结直肠肿瘤 基因表达 绿色荧光蛋白质类 过氧化还原蛋白2 慢病毒载体 colorectal neoplasms gene expression green fluorescent proteins peroxiredoxin 2 (PRDX2) lentivirus vector
  • 相关文献

参考文献15

  • 1Siegel R, Naishadham D,Jemal A. Cancer Statistics[J]. CA Cancer J Clin,2012,62(1) :10-29.
  • 2American Cancer Society. Colorectal cancer facts & figures EM]. Atlanta : ACS, 2011-2013.
  • 3王锡山.结直肠癌综合治疗的规范化实施[J].中国实用外科杂志,2010,30(4):260-264. 被引量:57
  • 4Wu XY, Fu ZX, Wang XH. Peroxiredoxins in colorectal neoplasms [J]. Histol Histopathol, 2010,25 (10): 1297- 1303.
  • 5Wood ZA, SehrOder E, Robin Harris J, et al. Structure, mechanism and regulation of peroxiredoxins[J]. Trends Bioehem Sei, 2003,28 ( 1 ) : 32-40.
  • 6Rhee SG,Kang SW,Jeong W,et al. Intracellular messen- ger function of hydrogen peroxide and its regulation by peroxiredoxins[J]. Curr Opin Cell Biol, 2005,17 (2): 183- 189.
  • 7Ishii T,Warabi E, Yanagawa T. Novel roles of peroxire- doxins in inflammation,cancer and innate immunity[J]. J Clin Biochem Nutr, 2012,50(2) : 91-105.
  • 8Godoy JR, Funke M, Ackermann W, et al. Redox atlas of the mouse. Immunohistochemical detection of glutaredox- in-,peroxiredoxin-, and thioredoxin-family proteins in va- rious tissues of the laboratory mouse[J]. Bioehim Biophys Acta,2011,1810(1) :2-92.
  • 9Han YH,Kwon J H, Yu DY, et al. Inhibitory effect of per- oxiredoxin II (Prx II ) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast(MEF) senescence[J]. Free Radic Res,2006,40(11) : 1182-1189.
  • 10Kang DH,Lee DJ, Lee KW, et al. Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells[J]. Molecular Cell, 2011,44 (4): 545- 558.

二级参考文献11

  • 1American Cancer Society. Cancer Facts & Figures 2009[ M ]. Atlanta: American Cancer Society, 2009 : 12-13.
  • 2De Paolie A. Innocente R, Buonadonna A, et al. Neoadjuvant therapy of rectal cancer : New treatment perspectives [J ]. Tumori, 2004, 90(4): 373-378.
  • 3Kapiteijn E, Marijnen CA, Nagtegal ID, et al. Preoperative radiotherapy combined with total wesorectal excision for resectable rectal cancer[J]. N Engl J Med, 2001, 345(9): 638-646.
  • 4Camma C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis [J]. JAMA ,2000, 284:1008-1015.
  • 5Adam R, Delvart V, Pascal G, et al.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival [J].Ann Surg,2004,240(4): 644 - 657.
  • 6Li e vre A, Bachet JB, Boige V, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab [J]. J Clin Oncol, 2008, 26: 374-379.
  • 7Tjandra JJ, Kilkenny JW, Buie WD, et al. Practice parameters for the management of rectal cancer (revised) [J]. Dis Colon Rectum, 2005, 48(3): 411-423.
  • 8Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a recta-analysis [J]. Lancet Oncol, 2009, 10(11):1053-1062.
  • 9Segelman J, Singnomklao T, Hellborg H, et al.Differenees in muhidisciplinary team assessment and treatment between patients with stage Ⅳ colon and rectal cancer. Colorectal Dis [J ]. 2009, 11(7):768-774.
  • 10王锡山.直肠癌选择性扩大根治术的可行性[J].中国实用外科杂志,2008,28(12):1032-1034. 被引量:5

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部